These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31234332)

  • 1. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines.
    Choi HS; Kim YK; Yun PY
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.
    Harada K; Ferdous T; Ueyama Y
    Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
    Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
    Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
    Lu X; Wang Z; Huang H; Wang H
    J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines.
    Choi HS; Kim YK; Hwang KG; Yun PY
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Epithelial-Mesenchymal Transition and Migration in Cisplatin-resistant Cancer Through Combined Treatment With Cisplatin and SH003.
    Choi HS; Ku JK; Ko SG; Yun PY
    Anticancer Res; 2024 Oct; 44(10):4359-4369. PubMed ID: 39348961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein.
    Chen WJ; Wang H; Tang Y; Liu CL; Li HL; Li WT
    Chin J Cancer; 2010 Feb; 29(2):151-7. PubMed ID: 20109342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
    Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
    Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
    Shi RZ; He YF; Wen J; Niu YN; Gao Y; Liu LH; Zhang XP; Wang Y; Zhang XL; Zhang HF; Chen M; Hu XL
    Cell Biol Int; 2021 Aug; 45(8):1644-1653. PubMed ID: 33760350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.
    Ghosh RD; Ghuwalewala S; Das P; Mandloi S; Alam SK; Chakraborty J; Sarkar S; Chakrabarti S; Panda CK; Roychoudhury S
    Sci Rep; 2016 Apr; 6():23932. PubMed ID: 27045798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stemness of CD10-positive cells regulated by Hedgehog pathway promotes the resistance to cisplatin in oral squamous cell carcinoma.
    Wang Y; Li Q; Xu L; Chen J; Pu Y; Wang L; Sun H; Guo Y; Guo C
    Oral Dis; 2021 Sep; 27(6):1403-1411. PubMed ID: 33037760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
    Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
    Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
    Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
    Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
    Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
    Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.